Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 07-2023 | 04-2023 | 01-2023 | 10-2022 | 07-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,528 | -14,878 | -11,573 | -6,147 | -3,037 |
| Depreciation Amortization | 13 | 23 | 18 | 12 | 7 |
| Other Working Capital | -153 | 2,349 | 1,776 | -329 | -374 |
| Other Operating Activity | 369 | 3,583 | 3,091 | 1,583 | 867 |
| Operating Cash Flow | $-3,298 | $-8,923 | $-6,688 | $-4,881 | $-2,537 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -147 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-147 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $0 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 5,141 | 14,064 | 14,064 | 14,064 | 14,064 |
| End Cash Position | 1,695 | 5,141 | 7,376 | 9,183 | 11,527 |
| Net Cash Flow | $-3,445 | $-8,923 | $-6,688 | $-4,881 | $-2,537 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,298 | -8,923 | -6,688 | -4,881 | -2,537 |
| Capital Expenditure | -147 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -3,445 | -8,923 | -6,688 | -4,881 | -2,537 |